Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: ease2002 ..."countless failures"?
1
Feb 17, 2010 08:51AM
3
Feb 17, 2010 11:32AM

If failure was to be part of the PTSC investment business, then they should have returned the MMP licensing royalties back to shareholders in the form of stock buybacks or dividends...PERIOD!!!!!!!!!!!!! Hopefully, these actions will be implemented in the future. I do believe that the dividends previously being paid to warrant holders turned a positive plan into a debilitating implementation that incensed shareholders.

The real problem is the BOD does not have the business expertise to identify, evaluate and monitor a venture capitalist business plan, especially as a silent partner.

Share
New Message
Please login to post a reply